Fundraising Fox
Q'Apel Medical
Fremont, US · Delaware corporation · 4 known investors
Find your way into Q'Apel Medical
Sign up to find every way you can get introduced to Q'Apel Medical
- Your email: who you already know at Q'Apel Medical, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Q'Apel Medical team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Q'Apel Medical designs purpose-built devices for neurovascular and stroke care, developing tools focused on catheter access and navigation through complex vascular pathways. It develops these solutions in collaboration with neurovascular clinicians to address unmet clinical needs during stroke interventions.
Founders & leadership
Board
Investors · 4
How we know: rccf.com · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$68.9M disclosed across 3 rounds · 2021–2024
▶$17.1MraisedMay 2024 · 6 investors · Other Health CareRule 506(b)
- R. King NelsonExecutive Officer, Director
- Scott HuennekensDirector
- Carter McNabbDirector
- Lennox KetnerDirector
- Christopher MartinDirector
- Offering amount
- $42.1M
- Amount sold
- $17.1M
- First sale
- Apr 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$29.9MraisedMay 2022 · 7 investors · Other Health CareRule 506(b)
- Scot HuennekensDirector
- J. Avi RoopDirector
- Carter McNabbDirector
- R. King NelsonExecutive Officer, Director
- Christopher MartinDirector
- Offering amount
- $33M
- Amount sold
- $29.9M
- First sale
- Mar 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$21.9MraisedFeb 2021 · 6 investors · Other Health CareRule 506(b)
- R. King NelsonExecutive Officer, Director
- Christopher MartinDirector
- J. Avi RoopDirector
- Carter McNabbDirector
- Scot HuennekensDirector
- Offering amount
- $22M
- Amount sold
- $21.9M
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as Q'Apel Medical.
Frequently asked questions
- What does Q'Apel Medical do?
- Q'Apel Medical designs purpose-built devices for neurovascular and stroke care, developing tools focused on catheter access and navigation through complex vascular pathways. It develops these solutions in collaboration with neurovascular clinicians to address unmet clinical needs during stroke interventions.
- Who are Q'Apel Medical's investors?
- Q'Apel Medical's investors include RC Capital, Research Corporation Technologies, River Cities Capital, Soleus Capital.
- How much funding has Q'Apel Medical raised?
- Q'Apel Medical has disclosed $68.9M raised across 3 rounds.
- Where is Q'Apel Medical headquartered?
- Q'Apel Medical is headquartered in Fremont, US.